TAMMY HURLEY: Open Payments
NPI 1255814190 · GRUNDY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 9 payments from 6 companies in 2025. Trend: 2023 $29 · 2024 $137 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $36 |
| Novo Nordisk Inc | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: XIFAXAN, CAPLYTA, UBRELVY, TRELEGY ELLIPTA, Veozah, Rybelsus, VRAYLAR, Ozempic.
Industry payments across VA — which companies pay providers there.
